These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16685435)

  • 1. Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: clinical implications.
    Ashida A; Boku N; Aoyagi K; Sato H; Tsubosa Y; Minashi K; Muto M; Ohtsu A; Ochiai A; Yoshida T; Yoshida S; Sasaki H
    Int J Oncol; 2006 Jun; 28(6):1345-52. PubMed ID: 16685435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Duong C; Greenawalt DM; Kowalczyk A; Ciavarella ML; Raskutti G; Murray WK; Phillips WA; Thomas RJ
    Ann Surg Oncol; 2007 Dec; 14(12):3602-9. PubMed ID: 17896157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
    Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
    Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of COX-2 for the effect of chemoradiotherapy on esophageal squamous cell carcinoma.
    Takatori H; Natsugoe S; Okumura H; Matsumoto M; Ishigami S; Owaki T; Aikou T
    Oncol Rep; 2005 Apr; 13(4):697-701. PubMed ID: 15756444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.
    Kang SY; Han JH; Lee KJ; Choi JH; Park JI; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Oh YT; Chun M; Kim JH; Sheen SS; Lim HY
    Clin Cancer Res; 2007 Jul; 13(14):4146-53. PubMed ID: 17634542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
    Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
    Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.
    Tougeron D; Di Fiore F; Hamidou H; Rigal O; Paillot B; Michel P
    Oncology; 2007; 73(5-6):328-34. PubMed ID: 18497505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
    Kunisaki C; Imada T; Yamada R; Hatori S; Kinbara K; Watai K; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    Hepatogastroenterology; 2006; 53(69):366-71. PubMed ID: 16795974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
    Kii T; Takiuchi H; Kawabe S; Gotoh M; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
    Jpn J Clin Oncol; 2007 Aug; 37(8):583-9. PubMed ID: 17709606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older.
    Kosugi S; Sasamoto R; Kanda T; Matsuki A; Hatakeyama K
    Jpn J Clin Oncol; 2009 Jun; 39(6):360-6. PubMed ID: 19389794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity prediction in esophageal squamous cell carcinoma: novel marker genes and efficacy-prediction formulae using their expression data.
    Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Noguchi T; Kawahara K; Natsugoe S; Aikou T; Okazaki Y; Hayashizaki Y; Sato Y; Todo S; Hiyama E; Nishiyama M
    Int J Oncol; 2006 May; 28(5):1153-62. PubMed ID: 16596231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma.
    Ishibashi Y; Hanyu N; Nakada K; Suzuki Y; Yamamoto T; Yanaga K; Ohkawa K; Hashimoto N; Nakajima T; Saito H; Matsushima M; Urashima M
    Cancer Res; 2003 Aug; 63(16):5159-64. PubMed ID: 12941848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
    Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
    Tachimori Y; Kanamori N; Uemura N; Hokamura N; Igaki H; Kato H
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.